Short‐Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B‐Cell Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study

Documenti analoghi

• Blinatumomab‐Associated Psychosis in an Adolescent With B‐Cell Acute Lymphoblastic Leukemia
  di: Eesha A. Zaheer, et al.
  Pubblicazione: (2026)
• Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West
  di: Angela Parra del Riego, et al.
  Pubblicazione: (2026)
• Late Onset Blinatumomab‐Related Neurotoxicity in a Child With B‐Cell Acute Lymphoblastic Leukemia
  di: Krunal Shah, et al.
  Pubblicazione: (2025)
• Prolonged Hypogammaglobulinemia in a Child With Down Syndrome After Treatment of Acute Lymphoblastic Leukemia With Immunochemotherapy Including Blinatumomab
  di: Reena Pabari, et al.
  Pubblicazione: (2025)
• Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
  di: Andrew E. Place, et al.
  Pubblicazione: (2025)